Global Targeted Drugs for NSCLC Market Growth (Status and Outlook) 2025-2031
According to this study, the global Targeted Drugs for NSCLC market size will reach US$ million by 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Targeted Drugs for NSCLC Industry Forecast” looks at past sales and reviews total world Targeted Drugs for NSCLC sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for NSCLC sales for 2025 through 2031. With Targeted Drugs for NSCLC sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for NSCLC industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for NSCLC landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Drugs for NSCLC portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for NSCLC market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for NSCLC and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for NSCLC.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for NSCLC market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Targeted Drugs for NSCLC Industry Forecast” looks at past sales and reviews total world Targeted Drugs for NSCLC sales in 2024, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for NSCLC sales for 2025 through 2031. With Targeted Drugs for NSCLC sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for NSCLC industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for NSCLC landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Drugs for NSCLC portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for NSCLC market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for NSCLC and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for NSCLC.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for NSCLC market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Target EGFR
- Target ALK
- Target HER2
- Target ROS1
- Target BRAF
- Target MEK
- Target VEGFR2
- Target VEGF
- Target MET
- Squamous Cell Carcinoma of NSCLC
- Adenocarcinoma of NSCLC
- Large Cell Carcinoma of NSCLC
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allergan
- Amgen
- ARIAD Pharmaceuticals (Takeda)
- Beacon Pharma Limited
- BeiGene
- Biocon
- Boehringer-Ingelheim
- Celgene Corporation
- Drug International Limted
- Fujifilm Kyowa Kirin Biologics
- Genvio Pharma Limited
- Hetero Drugs
- ImClone Systems ?(Eli Lilly)
- Incepta Pharmaceuticals
- Mylan
- Novartis
- Pfizer
- Reliance Lifesciences
- Roche
- AstraZeneca
- Cipla
- Teva
- OSI Pharmaceuticals
- Glenmark Pharmaceuticals
- Natco Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drugs for NSCLC Market Size (2020-2031)
2.1.2 Targeted Drugs for NSCLC Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Targeted Drugs for NSCLC by Country/Region (2020, 2024 & 2031)
2.2 Targeted Drugs for NSCLC Segment by Type
2.2.1 Target EGFR
2.2.2 Target ALK
2.2.3 Target HER2
2.2.4 Target ROS1
2.2.5 Target BRAF
2.2.6 Target MEK
2.2.7 Target VEGFR2
2.2.8 Target VEGF
2.2.9 Target MET
2.3 Targeted Drugs for NSCLC Market Size by Type
2.3.1 Targeted Drugs for NSCLC Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
2.4 Targeted Drugs for NSCLC Segment by Application
2.4.1 Squamous Cell Carcinoma of NSCLC
2.4.2 Adenocarcinoma of NSCLC
2.4.3 Large Cell Carcinoma of NSCLC
2.5 Targeted Drugs for NSCLC Market Size by Application
2.5.1 Targeted Drugs for NSCLC Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
3 TARGETED DRUGS FOR NSCLC MARKET SIZE BY PLAYER
3.1 Targeted Drugs for NSCLC Market Size Market Share by Player
3.1.1 Global Targeted Drugs for NSCLC Revenue by Player (2020-2025)
3.1.2 Global Targeted Drugs for NSCLC Revenue Market Share by Player (2020-2025)
3.2 Global Targeted Drugs for NSCLC Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUGS FOR NSCLC BY REGION
4.1 Targeted Drugs for NSCLC Market Size by Region (2020-2025)
4.2 Global Targeted Drugs for NSCLC Annual Revenue by Country/Region (2020-2025)
4.3 Americas Targeted Drugs for NSCLC Market Size Growth (2020-2025)
4.4 APAC Targeted Drugs for NSCLC Market Size Growth (2020-2025)
4.5 Europe Targeted Drugs for NSCLC Market Size Growth (2020-2025)
4.6 Middle East & Africa Targeted Drugs for NSCLC Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Targeted Drugs for NSCLC Market Size by Country (2020-2025)
5.2 Americas Targeted Drugs for NSCLC Market Size by Type (2020-2025)
5.3 Americas Targeted Drugs for NSCLC Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drugs for NSCLC Market Size by Region (2020-2025)
6.2 APAC Targeted Drugs for NSCLC Market Size by Type (2020-2025)
6.3 APAC Targeted Drugs for NSCLC Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drugs for NSCLC Market Size by Country (2020-2025)
7.2 Europe Targeted Drugs for NSCLC Market Size by Type (2020-2025)
7.3 Europe Targeted Drugs for NSCLC Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drugs for NSCLC by Region (2020-2025)
8.2 Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2020-2025)
8.3 Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUGS FOR NSCLC MARKET FORECAST
10.1 Global Targeted Drugs for NSCLC Forecast by Region (2026-2031)
10.1.1 Global Targeted Drugs for NSCLC Forecast by Region (2026-2031)
10.1.2 Americas Targeted Drugs for NSCLC Forecast
10.1.3 APAC Targeted Drugs for NSCLC Forecast
10.1.4 Europe Targeted Drugs for NSCLC Forecast
10.1.5 Middle East & Africa Targeted Drugs for NSCLC Forecast
10.2 Americas Targeted Drugs for NSCLC Forecast by Country (2026-2031)
10.2.1 United States Market Targeted Drugs for NSCLC Forecast
10.2.2 Canada Market Targeted Drugs for NSCLC Forecast
10.2.3 Mexico Market Targeted Drugs for NSCLC Forecast
10.2.4 Brazil Market Targeted Drugs for NSCLC Forecast
10.3 APAC Targeted Drugs for NSCLC Forecast by Region (2026-2031)
10.3.1 China Targeted Drugs for NSCLC Market Forecast
10.3.2 Japan Market Targeted Drugs for NSCLC Forecast
10.3.3 Korea Market Targeted Drugs for NSCLC Forecast
10.3.4 Southeast Asia Market Targeted Drugs for NSCLC Forecast
10.3.5 India Market Targeted Drugs for NSCLC Forecast
10.3.6 Australia Market Targeted Drugs for NSCLC Forecast
10.4 Europe Targeted Drugs for NSCLC Forecast by Country (2026-2031)
10.4.1 Germany Market Targeted Drugs for NSCLC Forecast
10.4.2 France Market Targeted Drugs for NSCLC Forecast
10.4.3 UK Market Targeted Drugs for NSCLC Forecast
10.4.4 Italy Market Targeted Drugs for NSCLC Forecast
10.4.5 Russia Market Targeted Drugs for NSCLC Forecast
10.5 Middle East & Africa Targeted Drugs for NSCLC Forecast by Region (2026-2031)
10.5.1 Egypt Market Targeted Drugs for NSCLC Forecast
10.5.2 South Africa Market Targeted Drugs for NSCLC Forecast
10.5.3 Israel Market Targeted Drugs for NSCLC Forecast
10.5.4 Turkey Market Targeted Drugs for NSCLC Forecast
10.6 Global Targeted Drugs for NSCLC Forecast by Type (2026-2031)
10.7 Global Targeted Drugs for NSCLC Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Targeted Drugs for NSCLC Forecast
11 KEY PLAYERS ANALYSIS
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Targeted Drugs for NSCLC Product Offered
11.1.3 Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Targeted Drugs for NSCLC Product Offered
11.2.3 Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 ARIAD Pharmaceuticals (Takeda)
11.3.1 ARIAD Pharmaceuticals (Takeda) Company Information
11.3.2 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Offered
11.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 ARIAD Pharmaceuticals (Takeda) Main Business Overview
11.3.5 ARIAD Pharmaceuticals (Takeda) Latest Developments
11.4 Beacon Pharma Limited
11.4.1 Beacon Pharma Limited Company Information
11.4.2 Beacon Pharma Limited Targeted Drugs for NSCLC Product Offered
11.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Beacon Pharma Limited Main Business Overview
11.4.5 Beacon Pharma Limited Latest Developments
11.5 BeiGene
11.5.1 BeiGene Company Information
11.5.2 BeiGene Targeted Drugs for NSCLC Product Offered
11.5.3 BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 BeiGene Main Business Overview
11.5.5 BeiGene Latest Developments
11.6 Biocon
11.6.1 Biocon Company Information
11.6.2 Biocon Targeted Drugs for NSCLC Product Offered
11.6.3 Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Biocon Main Business Overview
11.6.5 Biocon Latest Developments
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Information
11.7.2 Boehringer-Ingelheim Targeted Drugs for NSCLC Product Offered
11.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Boehringer-Ingelheim Main Business Overview
11.7.5 Boehringer-Ingelheim Latest Developments
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Information
11.8.2 Celgene Corporation Targeted Drugs for NSCLC Product Offered
11.8.3 Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Celgene Corporation Main Business Overview
11.8.5 Celgene Corporation Latest Developments
11.9 Drug International Limted
11.9.1 Drug International Limted Company Information
11.9.2 Drug International Limted Targeted Drugs for NSCLC Product Offered
11.9.3 Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Drug International Limted Main Business Overview
11.9.5 Drug International Limted Latest Developments
11.10 Fujifilm Kyowa Kirin Biologics
11.10.1 Fujifilm Kyowa Kirin Biologics Company Information
11.10.2 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Offered
11.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Fujifilm Kyowa Kirin Biologics Main Business Overview
11.10.5 Fujifilm Kyowa Kirin Biologics Latest Developments
11.11 Genvio Pharma Limited
11.11.1 Genvio Pharma Limited Company Information
11.11.2 Genvio Pharma Limited Targeted Drugs for NSCLC Product Offered
11.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Genvio Pharma Limited Main Business Overview
11.11.5 Genvio Pharma Limited Latest Developments
11.12 Hetero Drugs
11.12.1 Hetero Drugs Company Information
11.12.2 Hetero Drugs Targeted Drugs for NSCLC Product Offered
11.12.3 Hetero Drugs Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hetero Drugs Main Business Overview
11.12.5 Hetero Drugs Latest Developments
11.13 ImClone Systems ?(Eli Lilly)
11.13.1 ImClone Systems ?(Eli Lilly) Company Information
11.13.2 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Offered
11.13.3 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 ImClone Systems ?(Eli Lilly) Main Business Overview
11.13.5 ImClone Systems ?(Eli Lilly) Latest Developments
11.14 Incepta Pharmaceuticals
11.14.1 Incepta Pharmaceuticals Company Information
11.14.2 Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Incepta Pharmaceuticals Main Business Overview
11.14.5 Incepta Pharmaceuticals Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Targeted Drugs for NSCLC Product Offered
11.15.3 Mylan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Novartis
11.16.1 Novartis Company Information
11.16.2 Novartis Targeted Drugs for NSCLC Product Offered
11.16.3 Novartis Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Novartis Main Business Overview
11.16.5 Novartis Latest Developments
11.17 Pfizer
11.17.1 Pfizer Company Information
11.17.2 Pfizer Targeted Drugs for NSCLC Product Offered
11.17.3 Pfizer Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Pfizer Main Business Overview
11.17.5 Pfizer Latest Developments
11.18 Reliance Lifesciences
11.18.1 Reliance Lifesciences Company Information
11.18.2 Reliance Lifesciences Targeted Drugs for NSCLC Product Offered
11.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Reliance Lifesciences Main Business Overview
11.18.5 Reliance Lifesciences Latest Developments
11.19 Roche
11.19.1 Roche Company Information
11.19.2 Roche Targeted Drugs for NSCLC Product Offered
11.19.3 Roche Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Roche Main Business Overview
11.19.5 Roche Latest Developments
11.20 AstraZeneca
11.20.1 AstraZeneca Company Information
11.20.2 AstraZeneca Targeted Drugs for NSCLC Product Offered
11.20.3 AstraZeneca Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 AstraZeneca Main Business Overview
11.20.5 AstraZeneca Latest Developments
11.21 Cipla
11.21.1 Cipla Company Information
11.21.2 Cipla Targeted Drugs for NSCLC Product Offered
11.21.3 Cipla Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Cipla Main Business Overview
11.21.5 Cipla Latest Developments
11.22 Teva
11.22.1 Teva Company Information
11.22.2 Teva Targeted Drugs for NSCLC Product Offered
11.22.3 Teva Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Teva Main Business Overview
11.22.5 Teva Latest Developments
11.23 OSI Pharmaceuticals
11.23.1 OSI Pharmaceuticals Company Information
11.23.2 OSI Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 OSI Pharmaceuticals Main Business Overview
11.23.5 OSI Pharmaceuticals Latest Developments
11.24 Glenmark Pharmaceuticals
11.24.1 Glenmark Pharmaceuticals Company Information
11.24.2 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Glenmark Pharmaceuticals Main Business Overview
11.24.5 Glenmark Pharmaceuticals Latest Developments
11.25 Natco Pharma
11.25.1 Natco Pharma Company Information
11.25.2 Natco Pharma Targeted Drugs for NSCLC Product Offered
11.25.3 Natco Pharma Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Natco Pharma Main Business Overview
11.25.5 Natco Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drugs for NSCLC Market Size (2020-2031)
2.1.2 Targeted Drugs for NSCLC Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Targeted Drugs for NSCLC by Country/Region (2020, 2024 & 2031)
2.2 Targeted Drugs for NSCLC Segment by Type
2.2.1 Target EGFR
2.2.2 Target ALK
2.2.3 Target HER2
2.2.4 Target ROS1
2.2.5 Target BRAF
2.2.6 Target MEK
2.2.7 Target VEGFR2
2.2.8 Target VEGF
2.2.9 Target MET
2.3 Targeted Drugs for NSCLC Market Size by Type
2.3.1 Targeted Drugs for NSCLC Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
2.4 Targeted Drugs for NSCLC Segment by Application
2.4.1 Squamous Cell Carcinoma of NSCLC
2.4.2 Adenocarcinoma of NSCLC
2.4.3 Large Cell Carcinoma of NSCLC
2.5 Targeted Drugs for NSCLC Market Size by Application
2.5.1 Targeted Drugs for NSCLC Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
3 TARGETED DRUGS FOR NSCLC MARKET SIZE BY PLAYER
3.1 Targeted Drugs for NSCLC Market Size Market Share by Player
3.1.1 Global Targeted Drugs for NSCLC Revenue by Player (2020-2025)
3.1.2 Global Targeted Drugs for NSCLC Revenue Market Share by Player (2020-2025)
3.2 Global Targeted Drugs for NSCLC Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUGS FOR NSCLC BY REGION
4.1 Targeted Drugs for NSCLC Market Size by Region (2020-2025)
4.2 Global Targeted Drugs for NSCLC Annual Revenue by Country/Region (2020-2025)
4.3 Americas Targeted Drugs for NSCLC Market Size Growth (2020-2025)
4.4 APAC Targeted Drugs for NSCLC Market Size Growth (2020-2025)
4.5 Europe Targeted Drugs for NSCLC Market Size Growth (2020-2025)
4.6 Middle East & Africa Targeted Drugs for NSCLC Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Targeted Drugs for NSCLC Market Size by Country (2020-2025)
5.2 Americas Targeted Drugs for NSCLC Market Size by Type (2020-2025)
5.3 Americas Targeted Drugs for NSCLC Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drugs for NSCLC Market Size by Region (2020-2025)
6.2 APAC Targeted Drugs for NSCLC Market Size by Type (2020-2025)
6.3 APAC Targeted Drugs for NSCLC Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drugs for NSCLC Market Size by Country (2020-2025)
7.2 Europe Targeted Drugs for NSCLC Market Size by Type (2020-2025)
7.3 Europe Targeted Drugs for NSCLC Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drugs for NSCLC by Region (2020-2025)
8.2 Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2020-2025)
8.3 Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUGS FOR NSCLC MARKET FORECAST
10.1 Global Targeted Drugs for NSCLC Forecast by Region (2026-2031)
10.1.1 Global Targeted Drugs for NSCLC Forecast by Region (2026-2031)
10.1.2 Americas Targeted Drugs for NSCLC Forecast
10.1.3 APAC Targeted Drugs for NSCLC Forecast
10.1.4 Europe Targeted Drugs for NSCLC Forecast
10.1.5 Middle East & Africa Targeted Drugs for NSCLC Forecast
10.2 Americas Targeted Drugs for NSCLC Forecast by Country (2026-2031)
10.2.1 United States Market Targeted Drugs for NSCLC Forecast
10.2.2 Canada Market Targeted Drugs for NSCLC Forecast
10.2.3 Mexico Market Targeted Drugs for NSCLC Forecast
10.2.4 Brazil Market Targeted Drugs for NSCLC Forecast
10.3 APAC Targeted Drugs for NSCLC Forecast by Region (2026-2031)
10.3.1 China Targeted Drugs for NSCLC Market Forecast
10.3.2 Japan Market Targeted Drugs for NSCLC Forecast
10.3.3 Korea Market Targeted Drugs for NSCLC Forecast
10.3.4 Southeast Asia Market Targeted Drugs for NSCLC Forecast
10.3.5 India Market Targeted Drugs for NSCLC Forecast
10.3.6 Australia Market Targeted Drugs for NSCLC Forecast
10.4 Europe Targeted Drugs for NSCLC Forecast by Country (2026-2031)
10.4.1 Germany Market Targeted Drugs for NSCLC Forecast
10.4.2 France Market Targeted Drugs for NSCLC Forecast
10.4.3 UK Market Targeted Drugs for NSCLC Forecast
10.4.4 Italy Market Targeted Drugs for NSCLC Forecast
10.4.5 Russia Market Targeted Drugs for NSCLC Forecast
10.5 Middle East & Africa Targeted Drugs for NSCLC Forecast by Region (2026-2031)
10.5.1 Egypt Market Targeted Drugs for NSCLC Forecast
10.5.2 South Africa Market Targeted Drugs for NSCLC Forecast
10.5.3 Israel Market Targeted Drugs for NSCLC Forecast
10.5.4 Turkey Market Targeted Drugs for NSCLC Forecast
10.6 Global Targeted Drugs for NSCLC Forecast by Type (2026-2031)
10.7 Global Targeted Drugs for NSCLC Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Targeted Drugs for NSCLC Forecast
11 KEY PLAYERS ANALYSIS
11.1 Allergan
11.1.1 Allergan Company Information
11.1.2 Allergan Targeted Drugs for NSCLC Product Offered
11.1.3 Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Allergan Main Business Overview
11.1.5 Allergan Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Targeted Drugs for NSCLC Product Offered
11.2.3 Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
11.3 ARIAD Pharmaceuticals (Takeda)
11.3.1 ARIAD Pharmaceuticals (Takeda) Company Information
11.3.2 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Offered
11.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 ARIAD Pharmaceuticals (Takeda) Main Business Overview
11.3.5 ARIAD Pharmaceuticals (Takeda) Latest Developments
11.4 Beacon Pharma Limited
11.4.1 Beacon Pharma Limited Company Information
11.4.2 Beacon Pharma Limited Targeted Drugs for NSCLC Product Offered
11.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Beacon Pharma Limited Main Business Overview
11.4.5 Beacon Pharma Limited Latest Developments
11.5 BeiGene
11.5.1 BeiGene Company Information
11.5.2 BeiGene Targeted Drugs for NSCLC Product Offered
11.5.3 BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 BeiGene Main Business Overview
11.5.5 BeiGene Latest Developments
11.6 Biocon
11.6.1 Biocon Company Information
11.6.2 Biocon Targeted Drugs for NSCLC Product Offered
11.6.3 Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Biocon Main Business Overview
11.6.5 Biocon Latest Developments
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Information
11.7.2 Boehringer-Ingelheim Targeted Drugs for NSCLC Product Offered
11.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Boehringer-Ingelheim Main Business Overview
11.7.5 Boehringer-Ingelheim Latest Developments
11.8 Celgene Corporation
11.8.1 Celgene Corporation Company Information
11.8.2 Celgene Corporation Targeted Drugs for NSCLC Product Offered
11.8.3 Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Celgene Corporation Main Business Overview
11.8.5 Celgene Corporation Latest Developments
11.9 Drug International Limted
11.9.1 Drug International Limted Company Information
11.9.2 Drug International Limted Targeted Drugs for NSCLC Product Offered
11.9.3 Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Drug International Limted Main Business Overview
11.9.5 Drug International Limted Latest Developments
11.10 Fujifilm Kyowa Kirin Biologics
11.10.1 Fujifilm Kyowa Kirin Biologics Company Information
11.10.2 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Offered
11.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Fujifilm Kyowa Kirin Biologics Main Business Overview
11.10.5 Fujifilm Kyowa Kirin Biologics Latest Developments
11.11 Genvio Pharma Limited
11.11.1 Genvio Pharma Limited Company Information
11.11.2 Genvio Pharma Limited Targeted Drugs for NSCLC Product Offered
11.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Genvio Pharma Limited Main Business Overview
11.11.5 Genvio Pharma Limited Latest Developments
11.12 Hetero Drugs
11.12.1 Hetero Drugs Company Information
11.12.2 Hetero Drugs Targeted Drugs for NSCLC Product Offered
11.12.3 Hetero Drugs Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hetero Drugs Main Business Overview
11.12.5 Hetero Drugs Latest Developments
11.13 ImClone Systems ?(Eli Lilly)
11.13.1 ImClone Systems ?(Eli Lilly) Company Information
11.13.2 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Offered
11.13.3 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 ImClone Systems ?(Eli Lilly) Main Business Overview
11.13.5 ImClone Systems ?(Eli Lilly) Latest Developments
11.14 Incepta Pharmaceuticals
11.14.1 Incepta Pharmaceuticals Company Information
11.14.2 Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Incepta Pharmaceuticals Main Business Overview
11.14.5 Incepta Pharmaceuticals Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Targeted Drugs for NSCLC Product Offered
11.15.3 Mylan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Novartis
11.16.1 Novartis Company Information
11.16.2 Novartis Targeted Drugs for NSCLC Product Offered
11.16.3 Novartis Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Novartis Main Business Overview
11.16.5 Novartis Latest Developments
11.17 Pfizer
11.17.1 Pfizer Company Information
11.17.2 Pfizer Targeted Drugs for NSCLC Product Offered
11.17.3 Pfizer Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Pfizer Main Business Overview
11.17.5 Pfizer Latest Developments
11.18 Reliance Lifesciences
11.18.1 Reliance Lifesciences Company Information
11.18.2 Reliance Lifesciences Targeted Drugs for NSCLC Product Offered
11.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Reliance Lifesciences Main Business Overview
11.18.5 Reliance Lifesciences Latest Developments
11.19 Roche
11.19.1 Roche Company Information
11.19.2 Roche Targeted Drugs for NSCLC Product Offered
11.19.3 Roche Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Roche Main Business Overview
11.19.5 Roche Latest Developments
11.20 AstraZeneca
11.20.1 AstraZeneca Company Information
11.20.2 AstraZeneca Targeted Drugs for NSCLC Product Offered
11.20.3 AstraZeneca Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 AstraZeneca Main Business Overview
11.20.5 AstraZeneca Latest Developments
11.21 Cipla
11.21.1 Cipla Company Information
11.21.2 Cipla Targeted Drugs for NSCLC Product Offered
11.21.3 Cipla Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Cipla Main Business Overview
11.21.5 Cipla Latest Developments
11.22 Teva
11.22.1 Teva Company Information
11.22.2 Teva Targeted Drugs for NSCLC Product Offered
11.22.3 Teva Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 Teva Main Business Overview
11.22.5 Teva Latest Developments
11.23 OSI Pharmaceuticals
11.23.1 OSI Pharmaceuticals Company Information
11.23.2 OSI Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 OSI Pharmaceuticals Main Business Overview
11.23.5 OSI Pharmaceuticals Latest Developments
11.24 Glenmark Pharmaceuticals
11.24.1 Glenmark Pharmaceuticals Company Information
11.24.2 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Offered
11.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.24.4 Glenmark Pharmaceuticals Main Business Overview
11.24.5 Glenmark Pharmaceuticals Latest Developments
11.25 Natco Pharma
11.25.1 Natco Pharma Company Information
11.25.2 Natco Pharma Targeted Drugs for NSCLC Product Offered
11.25.3 Natco Pharma Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2020-2025)
11.25.4 Natco Pharma Main Business Overview
11.25.5 Natco Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Drugs for NSCLC Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Targeted Drugs for NSCLC Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Target EGFR
Table 4. Major Players of Target ALK
Table 5. Major Players of Target HER2
Table 6. Major Players of Target ROS1
Table 7. Major Players of Target BRAF
Table 8. Major Players of Target MEK
Table 9. Major Players of Target VEGFR2
Table 10. Major Players of Target VEGF
Table 11. Major Players of Target MET
Table 12. Targeted Drugs for NSCLC Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 14. Global Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Table 15. Targeted Drugs for NSCLC Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 16. Global Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 17. Global Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Table 18. Global Targeted Drugs for NSCLC Revenue by Player (2020-2025) & ($ millions)
Table 19. Global Targeted Drugs for NSCLC Revenue Market Share by Player (2020-2025)
Table 20. Targeted Drugs for NSCLC Key Players Head office and Products Offered
Table 21. Targeted Drugs for NSCLC Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Targeted Drugs for NSCLC Market Size by Region (2020-2025) & ($ millions)
Table 25. Global Targeted Drugs for NSCLC Market Size Market Share by Region (2020-2025)
Table 26. Global Targeted Drugs for NSCLC Revenue by Country/Region (2020-2025) & ($ millions)
Table 27. Global Targeted Drugs for NSCLC Revenue Market Share by Country/Region (2020-2025)
Table 28. Americas Targeted Drugs for NSCLC Market Size by Country (2020-2025) & ($ millions)
Table 29. Americas Targeted Drugs for NSCLC Market Size Market Share by Country (2020-2025)
Table 30. Americas Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 31. Americas Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Table 32. Americas Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 33. Americas Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Table 34. APAC Targeted Drugs for NSCLC Market Size by Region (2020-2025) & ($ millions)
Table 35. APAC Targeted Drugs for NSCLC Market Size Market Share by Region (2020-2025)
Table 36. APAC Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 37. APAC Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 38. Europe Targeted Drugs for NSCLC Market Size by Country (2020-2025) & ($ millions)
Table 39. Europe Targeted Drugs for NSCLC Market Size Market Share by Country (2020-2025)
Table 40. Europe Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 41. Europe Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 42. Middle East & Africa Targeted Drugs for NSCLC Market Size by Region (2020-2025) & ($ millions)
Table 43. Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 44. Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 45. Key Market Drivers & Growth Opportunities of Targeted Drugs for NSCLC
Table 46. Key Market Challenges & Risks of Targeted Drugs for NSCLC
Table 47. Key Industry Trends of Targeted Drugs for NSCLC
Table 48. Global Targeted Drugs for NSCLC Market Size Forecast by Region (2026-2031) & ($ millions)
Table 49. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Region (2026-2031)
Table 50. Global Targeted Drugs for NSCLC Market Size Forecast by Type (2026-2031) & ($ millions)
Table 51. Global Targeted Drugs for NSCLC Market Size Forecast by Application (2026-2031) & ($ millions)
Table 52. Allergan Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 53. Allergan Targeted Drugs for NSCLC Product Offered
Table 54. Allergan Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Allergan Main Business
Table 56. Allergan Latest Developments
Table 57. Amgen Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 58. Amgen Targeted Drugs for NSCLC Product Offered
Table 59. Amgen Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Amgen Main Business
Table 61. Amgen Latest Developments
Table 62. ARIAD Pharmaceuticals (Takeda) Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 63. ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Offered
Table 64. ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. ARIAD Pharmaceuticals (Takeda) Main Business
Table 66. ARIAD Pharmaceuticals (Takeda) Latest Developments
Table 67. Beacon Pharma Limited Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 68. Beacon Pharma Limited Targeted Drugs for NSCLC Product Offered
Table 69. Beacon Pharma Limited Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Beacon Pharma Limited Main Business
Table 71. Beacon Pharma Limited Latest Developments
Table 72. BeiGene Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 73. BeiGene Targeted Drugs for NSCLC Product Offered
Table 74. BeiGene Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. BeiGene Main Business
Table 76. BeiGene Latest Developments
Table 77. Biocon Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 78. Biocon Targeted Drugs for NSCLC Product Offered
Table 79. Biocon Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Biocon Main Business
Table 81. Biocon Latest Developments
Table 82. Boehringer-Ingelheim Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 83. Boehringer-Ingelheim Targeted Drugs for NSCLC Product Offered
Table 84. Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Boehringer-Ingelheim Main Business
Table 86. Boehringer-Ingelheim Latest Developments
Table 87. Celgene Corporation Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 88. Celgene Corporation Targeted Drugs for NSCLC Product Offered
Table 89. Celgene Corporation Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Celgene Corporation Main Business
Table 91. Celgene Corporation Latest Developments
Table 92. Drug International Limted Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 93. Drug International Limted Targeted Drugs for NSCLC Product Offered
Table 94. Drug International Limted Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Drug International Limted Main Business
Table 96. Drug International Limted Latest Developments
Table 97. Fujifilm Kyowa Kirin Biologics Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 98. Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Offered
Table 99. Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Fujifilm Kyowa Kirin Biologics Main Business
Table 101. Fujifilm Kyowa Kirin Biologics Latest Developments
Table 102. Genvio Pharma Limited Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 103. Genvio Pharma Limited Targeted Drugs for NSCLC Product Offered
Table 104. Genvio Pharma Limited Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. Genvio Pharma Limited Main Business
Table 106. Genvio Pharma Limited Latest Developments
Table 107. Hetero Drugs Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 108. Hetero Drugs Targeted Drugs for NSCLC Product Offered
Table 109. Hetero Drugs Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Hetero Drugs Main Business
Table 111. Hetero Drugs Latest Developments
Table 112. ImClone Systems ?(Eli Lilly) Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 113. ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Offered
Table 114. ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. ImClone Systems ?(Eli Lilly) Main Business
Table 116. ImClone Systems ?(Eli Lilly) Latest Developments
Table 117. Incepta Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 118. Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 119. Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. Incepta Pharmaceuticals Main Business
Table 121. Incepta Pharmaceuticals Latest Developments
Table 122. Mylan Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 123. Mylan Targeted Drugs for NSCLC Product Offered
Table 124. Mylan Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. Mylan Main Business
Table 126. Mylan Latest Developments
Table 127. Novartis Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 128. Novartis Targeted Drugs for NSCLC Product Offered
Table 129. Novartis Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. Novartis Main Business
Table 131. Novartis Latest Developments
Table 132. Pfizer Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 133. Pfizer Targeted Drugs for NSCLC Product Offered
Table 134. Pfizer Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. Pfizer Main Business
Table 136. Pfizer Latest Developments
Table 137. Reliance Lifesciences Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 138. Reliance Lifesciences Targeted Drugs for NSCLC Product Offered
Table 139. Reliance Lifesciences Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 140. Reliance Lifesciences Main Business
Table 141. Reliance Lifesciences Latest Developments
Table 142. Roche Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 143. Roche Targeted Drugs for NSCLC Product Offered
Table 144. Roche Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 145. Roche Main Business
Table 146. Roche Latest Developments
Table 147. AstraZeneca Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 148. AstraZeneca Targeted Drugs for NSCLC Product Offered
Table 149. AstraZeneca Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 150. AstraZeneca Main Business
Table 151. AstraZeneca Latest Developments
Table 152. Cipla Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 153. Cipla Targeted Drugs for NSCLC Product Offered
Table 154. Cipla Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 155. Cipla Main Business
Table 156. Cipla Latest Developments
Table 157. Teva Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 158. Teva Targeted Drugs for NSCLC Product Offered
Table 159. Teva Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 160. Teva Main Business
Table 161. Teva Latest Developments
Table 162. OSI Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 163. OSI Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 164. OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 165. OSI Pharmaceuticals Main Business
Table 166. OSI Pharmaceuticals Latest Developments
Table 167. Glenmark Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 168. Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 169. Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 170. Glenmark Pharmaceuticals Main Business
Table 171. Glenmark Pharmaceuticals Latest Developments
Table 172. Natco Pharma Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 173. Natco Pharma Targeted Drugs for NSCLC Product Offered
Table 174. Natco Pharma Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 175. Natco Pharma Main Business
Table 176. Natco Pharma Latest Developments
Table 1. Targeted Drugs for NSCLC Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Targeted Drugs for NSCLC Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Target EGFR
Table 4. Major Players of Target ALK
Table 5. Major Players of Target HER2
Table 6. Major Players of Target ROS1
Table 7. Major Players of Target BRAF
Table 8. Major Players of Target MEK
Table 9. Major Players of Target VEGFR2
Table 10. Major Players of Target VEGF
Table 11. Major Players of Target MET
Table 12. Targeted Drugs for NSCLC Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 14. Global Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Table 15. Targeted Drugs for NSCLC Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 16. Global Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 17. Global Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Table 18. Global Targeted Drugs for NSCLC Revenue by Player (2020-2025) & ($ millions)
Table 19. Global Targeted Drugs for NSCLC Revenue Market Share by Player (2020-2025)
Table 20. Targeted Drugs for NSCLC Key Players Head office and Products Offered
Table 21. Targeted Drugs for NSCLC Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Targeted Drugs for NSCLC Market Size by Region (2020-2025) & ($ millions)
Table 25. Global Targeted Drugs for NSCLC Market Size Market Share by Region (2020-2025)
Table 26. Global Targeted Drugs for NSCLC Revenue by Country/Region (2020-2025) & ($ millions)
Table 27. Global Targeted Drugs for NSCLC Revenue Market Share by Country/Region (2020-2025)
Table 28. Americas Targeted Drugs for NSCLC Market Size by Country (2020-2025) & ($ millions)
Table 29. Americas Targeted Drugs for NSCLC Market Size Market Share by Country (2020-2025)
Table 30. Americas Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 31. Americas Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Table 32. Americas Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 33. Americas Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Table 34. APAC Targeted Drugs for NSCLC Market Size by Region (2020-2025) & ($ millions)
Table 35. APAC Targeted Drugs for NSCLC Market Size Market Share by Region (2020-2025)
Table 36. APAC Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 37. APAC Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 38. Europe Targeted Drugs for NSCLC Market Size by Country (2020-2025) & ($ millions)
Table 39. Europe Targeted Drugs for NSCLC Market Size Market Share by Country (2020-2025)
Table 40. Europe Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 41. Europe Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 42. Middle East & Africa Targeted Drugs for NSCLC Market Size by Region (2020-2025) & ($ millions)
Table 43. Middle East & Africa Targeted Drugs for NSCLC Market Size by Type (2020-2025) & ($ millions)
Table 44. Middle East & Africa Targeted Drugs for NSCLC Market Size by Application (2020-2025) & ($ millions)
Table 45. Key Market Drivers & Growth Opportunities of Targeted Drugs for NSCLC
Table 46. Key Market Challenges & Risks of Targeted Drugs for NSCLC
Table 47. Key Industry Trends of Targeted Drugs for NSCLC
Table 48. Global Targeted Drugs for NSCLC Market Size Forecast by Region (2026-2031) & ($ millions)
Table 49. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Region (2026-2031)
Table 50. Global Targeted Drugs for NSCLC Market Size Forecast by Type (2026-2031) & ($ millions)
Table 51. Global Targeted Drugs for NSCLC Market Size Forecast by Application (2026-2031) & ($ millions)
Table 52. Allergan Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 53. Allergan Targeted Drugs for NSCLC Product Offered
Table 54. Allergan Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Allergan Main Business
Table 56. Allergan Latest Developments
Table 57. Amgen Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 58. Amgen Targeted Drugs for NSCLC Product Offered
Table 59. Amgen Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Amgen Main Business
Table 61. Amgen Latest Developments
Table 62. ARIAD Pharmaceuticals (Takeda) Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 63. ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Product Offered
Table 64. ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. ARIAD Pharmaceuticals (Takeda) Main Business
Table 66. ARIAD Pharmaceuticals (Takeda) Latest Developments
Table 67. Beacon Pharma Limited Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 68. Beacon Pharma Limited Targeted Drugs for NSCLC Product Offered
Table 69. Beacon Pharma Limited Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Beacon Pharma Limited Main Business
Table 71. Beacon Pharma Limited Latest Developments
Table 72. BeiGene Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 73. BeiGene Targeted Drugs for NSCLC Product Offered
Table 74. BeiGene Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. BeiGene Main Business
Table 76. BeiGene Latest Developments
Table 77. Biocon Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 78. Biocon Targeted Drugs for NSCLC Product Offered
Table 79. Biocon Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Biocon Main Business
Table 81. Biocon Latest Developments
Table 82. Boehringer-Ingelheim Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 83. Boehringer-Ingelheim Targeted Drugs for NSCLC Product Offered
Table 84. Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Boehringer-Ingelheim Main Business
Table 86. Boehringer-Ingelheim Latest Developments
Table 87. Celgene Corporation Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 88. Celgene Corporation Targeted Drugs for NSCLC Product Offered
Table 89. Celgene Corporation Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Celgene Corporation Main Business
Table 91. Celgene Corporation Latest Developments
Table 92. Drug International Limted Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 93. Drug International Limted Targeted Drugs for NSCLC Product Offered
Table 94. Drug International Limted Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Drug International Limted Main Business
Table 96. Drug International Limted Latest Developments
Table 97. Fujifilm Kyowa Kirin Biologics Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 98. Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Product Offered
Table 99. Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Fujifilm Kyowa Kirin Biologics Main Business
Table 101. Fujifilm Kyowa Kirin Biologics Latest Developments
Table 102. Genvio Pharma Limited Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 103. Genvio Pharma Limited Targeted Drugs for NSCLC Product Offered
Table 104. Genvio Pharma Limited Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. Genvio Pharma Limited Main Business
Table 106. Genvio Pharma Limited Latest Developments
Table 107. Hetero Drugs Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 108. Hetero Drugs Targeted Drugs for NSCLC Product Offered
Table 109. Hetero Drugs Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Hetero Drugs Main Business
Table 111. Hetero Drugs Latest Developments
Table 112. ImClone Systems ?(Eli Lilly) Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 113. ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Product Offered
Table 114. ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. ImClone Systems ?(Eli Lilly) Main Business
Table 116. ImClone Systems ?(Eli Lilly) Latest Developments
Table 117. Incepta Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 118. Incepta Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 119. Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. Incepta Pharmaceuticals Main Business
Table 121. Incepta Pharmaceuticals Latest Developments
Table 122. Mylan Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 123. Mylan Targeted Drugs for NSCLC Product Offered
Table 124. Mylan Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. Mylan Main Business
Table 126. Mylan Latest Developments
Table 127. Novartis Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 128. Novartis Targeted Drugs for NSCLC Product Offered
Table 129. Novartis Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. Novartis Main Business
Table 131. Novartis Latest Developments
Table 132. Pfizer Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 133. Pfizer Targeted Drugs for NSCLC Product Offered
Table 134. Pfizer Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. Pfizer Main Business
Table 136. Pfizer Latest Developments
Table 137. Reliance Lifesciences Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 138. Reliance Lifesciences Targeted Drugs for NSCLC Product Offered
Table 139. Reliance Lifesciences Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 140. Reliance Lifesciences Main Business
Table 141. Reliance Lifesciences Latest Developments
Table 142. Roche Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 143. Roche Targeted Drugs for NSCLC Product Offered
Table 144. Roche Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 145. Roche Main Business
Table 146. Roche Latest Developments
Table 147. AstraZeneca Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 148. AstraZeneca Targeted Drugs for NSCLC Product Offered
Table 149. AstraZeneca Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 150. AstraZeneca Main Business
Table 151. AstraZeneca Latest Developments
Table 152. Cipla Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 153. Cipla Targeted Drugs for NSCLC Product Offered
Table 154. Cipla Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 155. Cipla Main Business
Table 156. Cipla Latest Developments
Table 157. Teva Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 158. Teva Targeted Drugs for NSCLC Product Offered
Table 159. Teva Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 160. Teva Main Business
Table 161. Teva Latest Developments
Table 162. OSI Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 163. OSI Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 164. OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 165. OSI Pharmaceuticals Main Business
Table 166. OSI Pharmaceuticals Latest Developments
Table 167. Glenmark Pharmaceuticals Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 168. Glenmark Pharmaceuticals Targeted Drugs for NSCLC Product Offered
Table 169. Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 170. Glenmark Pharmaceuticals Main Business
Table 171. Glenmark Pharmaceuticals Latest Developments
Table 172. Natco Pharma Details, Company Type, Targeted Drugs for NSCLC Area Served and Its Competitors
Table 173. Natco Pharma Targeted Drugs for NSCLC Product Offered
Table 174. Natco Pharma Targeted Drugs for NSCLC Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 175. Natco Pharma Main Business
Table 176. Natco Pharma Latest Developments
LIST OF FIGURES
Figure 1. Targeted Drugs for NSCLC Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drugs for NSCLC Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Targeted Drugs for NSCLC Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Targeted Drugs for NSCLC Sales Market Share by Country/Region (2024)
Figure 8. Targeted Drugs for NSCLC Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Targeted Drugs for NSCLC Market Size Market Share by Type in 2024
Figure 10. Targeted Drugs for NSCLC in Squamous Cell Carcinoma of NSCLC
Figure 11. Global Targeted Drugs for NSCLC Market: Squamous Cell Carcinoma of NSCLC (2020-2025) & ($ millions)
Figure 12. Targeted Drugs for NSCLC in Adenocarcinoma of NSCLC
Figure 13. Global Targeted Drugs for NSCLC Market: Adenocarcinoma of NSCLC (2020-2025) & ($ millions)
Figure 14. Targeted Drugs for NSCLC in Large Cell Carcinoma of NSCLC
Figure 15. Global Targeted Drugs for NSCLC Market: Large Cell Carcinoma of NSCLC (2020-2025) & ($ millions)
Figure 16. Global Targeted Drugs for NSCLC Market Size Market Share by Application in 2024
Figure 17. Global Targeted Drugs for NSCLC Revenue Market Share by Player in 2024
Figure 18. Global Targeted Drugs for NSCLC Market Size Market Share by Region (2020-2025)
Figure 19. Americas Targeted Drugs for NSCLC Market Size 2020-2025 ($ millions)
Figure 20. APAC Targeted Drugs for NSCLC Market Size 2020-2025 ($ millions)
Figure 21. Europe Targeted Drugs for NSCLC Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Targeted Drugs for NSCLC Market Size 2020-2025 ($ millions)
Figure 23. Americas Targeted Drugs for NSCLC Value Market Share by Country in 2024
Figure 24. United States Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Targeted Drugs for NSCLC Market Size Market Share by Region in 2024
Figure 29. APAC Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Figure 30. APAC Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Figure 31. China Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 35. India Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Targeted Drugs for NSCLC Market Size Market Share by Country in 2024
Figure 38. Europe Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Figure 39. Europe Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Figure 40. Germany Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 41. France Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 54. APAC Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 55. Europe Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 57. United States Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 58. Canada Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 59. Mexico Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 60. Brazil Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 61. China Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 62. Japan Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 63. Korea Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 65. India Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 66. Australia Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 67. Germany Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 68. France Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 69. UK Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 70. Italy Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 71. Russia Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 72. Egypt Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 73. South Africa Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 74. Israel Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 75. Turkey Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 76. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 1. Targeted Drugs for NSCLC Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drugs for NSCLC Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Targeted Drugs for NSCLC Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Targeted Drugs for NSCLC Sales Market Share by Country/Region (2024)
Figure 8. Targeted Drugs for NSCLC Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Targeted Drugs for NSCLC Market Size Market Share by Type in 2024
Figure 10. Targeted Drugs for NSCLC in Squamous Cell Carcinoma of NSCLC
Figure 11. Global Targeted Drugs for NSCLC Market: Squamous Cell Carcinoma of NSCLC (2020-2025) & ($ millions)
Figure 12. Targeted Drugs for NSCLC in Adenocarcinoma of NSCLC
Figure 13. Global Targeted Drugs for NSCLC Market: Adenocarcinoma of NSCLC (2020-2025) & ($ millions)
Figure 14. Targeted Drugs for NSCLC in Large Cell Carcinoma of NSCLC
Figure 15. Global Targeted Drugs for NSCLC Market: Large Cell Carcinoma of NSCLC (2020-2025) & ($ millions)
Figure 16. Global Targeted Drugs for NSCLC Market Size Market Share by Application in 2024
Figure 17. Global Targeted Drugs for NSCLC Revenue Market Share by Player in 2024
Figure 18. Global Targeted Drugs for NSCLC Market Size Market Share by Region (2020-2025)
Figure 19. Americas Targeted Drugs for NSCLC Market Size 2020-2025 ($ millions)
Figure 20. APAC Targeted Drugs for NSCLC Market Size 2020-2025 ($ millions)
Figure 21. Europe Targeted Drugs for NSCLC Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Targeted Drugs for NSCLC Market Size 2020-2025 ($ millions)
Figure 23. Americas Targeted Drugs for NSCLC Value Market Share by Country in 2024
Figure 24. United States Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Targeted Drugs for NSCLC Market Size Market Share by Region in 2024
Figure 29. APAC Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Figure 30. APAC Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Figure 31. China Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 35. India Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Targeted Drugs for NSCLC Market Size Market Share by Country in 2024
Figure 38. Europe Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Figure 39. Europe Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Figure 40. Germany Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 41. France Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Targeted Drugs for NSCLC Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Targeted Drugs for NSCLC Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 54. APAC Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 55. Europe Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 57. United States Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 58. Canada Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 59. Mexico Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 60. Brazil Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 61. China Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 62. Japan Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 63. Korea Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 65. India Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 66. Australia Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 67. Germany Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 68. France Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 69. UK Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 70. Italy Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 71. Russia Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 72. Egypt Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 73. South Africa Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 74. Israel Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 75. Turkey Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
Figure 76. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Targeted Drugs for NSCLC Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Targeted Drugs for NSCLC Market Size 2026-2031 ($ millions)
